Three years after its establishment, the Hellenic Precision Medicine network has performed more than 5000 tests for oncogenic lesions (hematologic malignancies, solid tumors, hereditary cancer syndromes) as well as immunogenic markers for Chronic Lymphocytic Leukemia.
